Tower Research Capital LLC (Trc) Arcturus Therapeutics Holdings Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.53 Billion
Q2 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,571 shares of ARCT stock, worth $56,253. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,571

Previous 6,476 60.3%

Holding current value

$56,253

Previous $68,000 51.47%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$8.91 - $14.41 $34,793 - $56,271	-3,905 Reduced 60.3%	2,571 $33,000
Q1 2025 May 15, 2025	BUY	$10.59 - $20.83 $65,329 - $128,500	6,169 Added 2009.45%	6,476 $68,000
Q4 2024 Feb 13, 2025	SELL	$14.82 - $25.48 $52,507 - $90,275	-3,543 Reduced 92.03%	307 $5,000
Q3 2024 Nov 14, 2024	BUY	$18.08 - $25.38 $14,626 - $20,532	809 Added 26.6%	3,850 $89,000
Q2 2024 Aug 13, 2024	BUY	$24.35 - $44.39 $58,513 - $106,669	2,403 Added 376.65%	3,041 $74,000
Q1 2024 May 15, 2024	SELL	$31.23 - $42.99 $279,321 - $384,502	-8,944 Reduced 93.34%	638 $21,000
Q4 2023 Feb 13, 2024	BUY	$17.71 - $32.97 $140,511 - $261,583	7,934 Added 481.43%	9,582 $302,000
Q3 2023 Nov 14, 2023	SELL	$25.44 - $37.35 $279,051 - $409,692	-10,969 Reduced 86.94%	1,648 $42,000
Q2 2023 Aug 14, 2023	BUY	$23.94 - $32.36 $168,202 - $227,361	7,026 Added 125.67%	12,617 $361,000
Q1 2023 May 09, 2023	BUY	$14.72 - $23.97 $68,506 - $111,556	4,654 Added 496.69%	5,591 $134,000
Q4 2022 Feb 10, 2023	SELL	$14.14 - $23.06 $39,450 - $64,337	-2,790 Reduced 74.86%	937 $16,000
Q3 2022 Nov 10, 2022	SELL	$13.05 - $22.13 $44,409 - $75,308	-3,403 Reduced 47.73%	3,727 $55,000
Q2 2022 Aug 15, 2022	BUY	$12.26 - $31.17 $83,306 - $211,800	6,795 Added 2028.36%	7,130 $112,000
Q1 2022 May 12, 2022	SELL	$17.64 - $39.57 $35,068 - $78,665	-1,988 Reduced 85.58%	335 $9,000
Q4 2021 Feb 14, 2022	SELL	$34.2 - $47.56 $84,234 - $117,140	-2,463 Reduced 51.46%	2,323 $86,000
Q3 2021 Nov 15, 2021	BUY	$27.88 - $58.25 $94,401 - $197,234	3,386 Added 241.86%	4,786 $229,000
Q2 2021 Aug 16, 2021	SELL	$25.79 - $42.11 $231,001 - $377,179	-8,957 Reduced 86.48%	1,400 $47,000
Q1 2021 May 17, 2021	BUY	$38.75 - $86.92 $77,190 - $173,144	1,992 Added 23.81%	10,357 $428,000
Q4 2020 Feb 16, 2021	BUY	$34.61 - $123.66 $148,926 - $532,108	4,303 Added 105.93%	8,365 $363,000
Q3 2020 Nov 16, 2020	BUY	$37.49 - $63.19 $125,029 - $210,738	3,335 Added 458.73%	4,062 $174,000
Q2 2020 Aug 13, 2020	BUY	$12.66 - $58.27 $9,203 - $42,362	727 New	727 $34,000
Q1 2020 May 15, 2020	SELL	$9.31 - $18.26 $33,227 - $65,169	-3,569 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$8.93 - $12.41 $31,871 - $44,291	3,569 New	3,569 $39,000
Q3 2019 Nov 05, 2019	SELL	$8.8 - $14.5 $457 - $754	-52 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$5.78 - $9.79 $300 - $509	52 New	52 $0

Others Institutions Holding ARCT

# of Institutions

171

Shares Held

25.9M

Call Options Held

321K

Put Options Held

136K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $581M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Arcturus Therapeutics Holdings Inc. Transaction History